Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialNEAL FRANZ, David; BELOUSOVA, Elena; CURATOLO, Paolo et al.Lancet (British edition). 2013, Vol 381, Num 9861, pp 125-132, issn 0140-6736, 8 p.Article

Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issuesFERTE, Charles; PACI, Angelo; ZIZI, Meriem et al.European journal of cancer (1990). 2011, Vol 47, Num 15, pp 2249-2255, issn 0959-8049, 7 p.Article

Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 studyCAMPONE, Mario; BACHELOT, Thomas; BURRIS, Howard A et al.European journal of cancer (1990). 2013, Vol 49, Num 12, pp 2621-2632, issn 0959-8049, 12 p.Article

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancerJERUSALEM, Guy; FASOLO, Angelica; DIERAS, Veronique et al.Breast cancer research and treatment. 2011, Vol 125, Num 2, pp 447-455, issn 0167-6806, 9 p.Article

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 StudyOHTSU, Atsushi; AJANI, Jaffer A; MURO, Kei et al.Journal of clinical oncology. 2013, Vol 31, Num 31, pp 3935-3943, issn 0732-183X, 9 p.Article

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapyHURVITZ, Sara A; DALENC, Florence; MIAO, Sara et al.Breast cancer research and treatment. 2013, Vol 141, Num 3, pp 437-446, issn 0167-6806, 10 p.Conference Paper

Health-Related Quality of Life of Patients With Advanced Breast Cancer Treated With Everolimus Plus Exemestane Versus Placebo Plus Exemestane in the Phase 3, Randomized, Controlled, BOLERO-2 TrialBURRIS, Howard A; LEBRUN, Fabienne; CHOUINARD, Edmond et al.Cancer. 2013, Vol 119, Num 10, pp 1908-1915, issn 0008-543X, 8 p.Article

Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2^― advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapyCAMPONE, Mario; THADDEUS BECK, J; NUNZI, Martina et al.Current medical research and opinion. 2013, Vol 29, Num 11, pp 1463-1473, issn 0300-7995, 11 p.Article

Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With TrastuzumabANDRE, Fabrice; CAMPONE, Mario; O'REGAN, Ruth et al.Journal of clinical oncology. 2010, Vol 28, Num 34, pp 5110-5115, issn 0732-183X, 6 p.Article

Treatment of brain metastases of small-cell lung cancer : Comparing teniposide and teniposide with whole-brain radiotherapy: A phase III study of the european organization for the research and treatment of cancer lung cancer cooperative groupPOSTMUS, Pieter E; HAAXMA-REICHE, Hanny; SAHMOUD, Tarek et al.Journal of clinical oncology. 2000, Vol 18, Num 19, pp 3400-3408, issn 0732-183XArticle

Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2GNANT, Michael; BASELGA, Jose; GEBERTH, Matthias et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 9, pp 654-663, issn 0027-8874, 10 p.Article

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialBISSLER, John J; CHRISTOPHER KINGSWOOD, J; WHITTEMORE, Vicky H et al.Lancet (British edition). 2013, Vol 381, Num 9869, pp 817-824, issn 0140-6736, 8 p.Article

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast CancerBASELGA, Jose; CAMPONE, Mario; THADDEUS BECK, J et al.The New England journal of medicine. 2012, Vol 366, Num 6, pp 520-529, issn 0028-4793, 10 p.Article

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous SclerosisKRUEGER, Darcy A; CARE, Marguerite M; HOLLAND, Katherine et al.The New England journal of medicine. 2010, Vol 363, Num 19, pp 1801-1811, issn 0028-4793, 11 p.Article

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysisBONNETERRE, Jacques; BUZDAR, Aman; NABHOLTZ, Jean-Marc A et al.Cancer. 2001, Vol 92, Num 9, pp 2247-2258, issn 0008-543XArticle

Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial multivariate analysis with Ki-67 index, mitotic count, and microvessel densityMANDARD, Anne Marie; DENOUX, Yves; HERLIN, Paulette et al.Cancer. 2000, Vol 89, Num 8, pp 1748-1757, issn 0008-543XConference Paper